Platelets in Pregnancy
NCT06194643 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2025-09-18
Summary
This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in patient's as a result of aspirin use and their association with adverse perinatal outcomes.
Conditions
- Hypertensive Disorder of Pregnancy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Christina A. Penfield, MD, MPH · NYU Langone Health
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-17
- Primary Completion
- 2025-01-08
- Completion
- 2026-03-31
Countries
- United States
Study Locations
More Related Trials
-
The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies
NCT03746028 ·Status: UNKNOWN
-
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
NCT01352234 ·Status: COMPLETED ·Phase: PHASE4
-
Autophagy/Apoptosis Balance in Placental Vascular Pathologies
NCT06779916 ·Status: RECRUITING
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study
NCT00763672 ·Status: COMPLETED ·Phase: NA
-
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
NCT03528967 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.
NCT02174328 ·Status: TERMINATED ·Phase: PHASE3
-
Oxford Luteal Dysfunction and Placental Insufficiency Study
NCT07072052 ·Status: NOT_YET_RECRUITING
-
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
NCT06115122 ·Status: RECRUITING
-
Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy
NCT00319176 ·Status: COMPLETED
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
NCT03100123 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
NCT03552055 ·Status: COMPLETED
-
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
NCT06408181 ·Status: RECRUITING ·Phase: PHASE3
-
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
NCT05625724 ·Status: RECRUITING ·Phase: PHASE3
-
Promacta Pregnancy Registry
NCT01064336 ·Status: COMPLETED
-
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 ·Status: COMPLETED
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED
-
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension
NCT04908982 ·Status: UNKNOWN ·Phase: PHASE4
-
Daily Aspirin Treatment After Preeclampsia
NCT06168461 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Immune Thrombocytopenia in Pregnancy
NCT02892630 ·Status: UNKNOWN
-
Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development
NCT02639676 ·Status: COMPLETED
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Mechanism of Thrombocytopenia in Infants
NCT00333333 ·Status: COMPLETED